Medistem Laboratories, Inc. (MDSM) announced today that its scientists have co-authored a paper proposing a new leukemia treatment.
In the Journal of Translational Medicine, the paper titled “Therapeutic use of Aldara in Chronic Myeloid Leukemia” is aimed to spur scientific interest in the connection between stem cells and the immune system.
Let us hear your thoughts below: